Document version control Revision History Version
Date
Section/ Appendix
Summary of Changes Section A
Section 8.2
Updated table ‘vaccine shelf life of vaccines’
Section 8.5.1
Amendments to permissible stock movement, indicating that all cold chain requirements are required to be met
Section 8.5.2
Added paragraph in section ‘Restriction on Transport Durations’ for Paediatric Pfizer
Section 9.1.6
New section ‘Paediatric Pfizer (5 to 11 years) Vaccines Quantities and Unit.
Table 9.2
Heading amendment to clarify these consumables are for the Pfizer vaccine. The table has been updated to remove items no longer supplied as part of this pack
Table 9.3
Saline added as now an ‘order as required’ item
Table 9.4
AstraZeneca consumables table added to include the flu+ syringe
Section 9.2.1
Updated ‘Delivery temperature and expiry dates’ section Section B
v31.0
24/12/21
Section 16.1
Introduction paragraph updated.
Table 18.3
Pfizer booster interval updated to 4 months.
Section 18.3
‘Active monitoring: Post Vaccine Symptom Check’ section updated. This will be sent out to up to 25% of consumers. Updated information about the group of people being contacted. Section C
New section: Paediatric Pfizer COVID-19 Vaccines (for age 5 to 11 years) Section D Updated to include AstraZeneca booster. Note: A prescription is still required. Section E Section 35
NIBS chapter updated with 5- to 11-year-old information. Under ‘Pre-event’.
Section 36.4
Adverse events after observation period updated with more information on Pfizer and AstraZeneca adverse events.
Section 36.6
Added sentence in the last paragraph ‘Please provide as much detail as possible about the error that occurred, any actions that were taken at the time of the event, and pending actions.’ Appendices No changes
Version 33.0 Page 155
